Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Castle Biosciences stock
Learn how to easily invest in Castle Biosciences stock.
Castle Biosciences Inc is a diagnostics & research business based in the US. Castle Biosciences shares (CSTL) are listed on the NASDAQ and all prices are listed in US Dollars. Castle Biosciences employs 311 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Castle Biosciences
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CSTL – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Castle Biosciences stock price (NASDAQ: CSTL)Use our graph to track the performance of CSTL stocks over time.
Castle Biosciences shares at a glance
|Latest market close||$35.56|
|52-week range||$31.51 - $107.69|
|50-day moving average||$42.53|
|200-day moving average||$60.92|
|Wall St. target price||$81.29|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.24|
Buy Castle Biosciences shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Castle Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Castle Biosciences price performance over time
|1 week (2022-01-21)||5.83%|
|1 month (2021-12-28)||-13.69%|
|3 months (2021-10-28)||-44.34%|
|6 months (2021-07-28)||-48.20%|
|1 year (2021-01-28)||-48.10%|
|2 years (2020-01-28)||18.61%|
|3 years (2019-01-24)||N/A|
|5 years (2017-01-24)||N/A|
Is Castle Biosciences stock undervalued or overvalued?
Valuing Castle Biosciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Castle Biosciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Castle Biosciences's EBITDA
Castle Biosciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5.9 million.
The EBITDA is a measure of a Castle Biosciences's overall financial performance and is widely used to measure a its profitability.
Castle Biosciences financials
|Revenue TTM||$86.3 million|
|Gross profit TTM||$53 million|
|Return on assets TTM||-5.79%|
|Return on equity TTM||-10.29%|
|Market capitalisation||$896.6 million|
TTM: trailing 12 months
Castle Biosciences share dividends
We're not expecting Castle Biosciences to pay a dividend over the next 12 months.
Castle Biosciences share price volatility
Over the last 12 months, Castle Biosciences's shares have ranged in value from as little as $31.51 up to $107.69. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Castle Biosciences's is 0.5837. This would suggest that Castle Biosciences's shares are less volatile than average (for this exchange).
Castle Biosciences overview
Castle Biosciences, Inc. , a commercial-stage dermatological cancer company, focuses to provide diagnostic and prognostic solutions for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify high-risk patients with stage I and II melanomas based on biological information from 31 genes within their tumor tissue. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma, a proprietary GEP test for suspicious pigmented lesions. It offers test services through physicians and their patients. The company was founded in 2007 and is headquartered in Friendswood, Texas. .
Castle Biosciences in the news
Netflix shares fall near pre-pandemic level as investors fear slowing subscriber growth, competition
Stocks making the biggest moves midday: Netflix, Kohl's, Wynn Resorts, General Motors and more
RBC upgrades Comcast to outperform on subscriber growth
Frequently asked questionsWhat percentage of Castle Biosciences is owned by insiders or institutions?
Currently 9.422% of Castle Biosciences shares are held by insiders and 87.627% by institutions. How many people work for Castle Biosciences?
Latest data suggests 311 work at Castle Biosciences. When does the fiscal year end for Castle Biosciences?
Castle Biosciences's fiscal year ends in December. Where is Castle Biosciences based?
Castle Biosciences's address is: 505 South Friendswood Drive, Friendswood, TX, United States, 77546 What is Castle Biosciences's ISIN number?
Castle Biosciences's international securities identification number is: US14843C1053 What is Castle Biosciences's CUSIP number?
Castle Biosciences's Committee on Uniform Securities Identification Procedures number is: 147905103
More guides on Finder
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.
Stocks are dropping; 3 rules for buying on the dip
Downturns often let you buy fundamentally strong stocks at bargain prices, but mind the fundamentals and consider these 3 rules.
The crypto market has lost $1.5 trillion in value — time to buy?
The crypto market wiped out $1.5 trillion in value in just three months.
Bitcoin tumbles past $40,000, altcoins follow
Bitcoin breached the $40,000 price level and may plummet lower as Russia signals a potential ban.
Cardano’s Pavia plot sale shows land rush is on in the metaverse
Cardano’s first metaverse project is available to investors now — if you can find a piece of digital land on sale. Plots sold fast despite the project’s early stage limitations.
Walmart dives deep into the metaverse with crypto and NFTs
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Today’s top U.S. stocks: Mechel Pao ADRs (MTL ↑8.1%), Sibanye-Stillwater Limited (SBSW ↑7.4%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
How to order free at-home COVID tests today — but note, there’s a wait
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
Ask an Expert